Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,000
Closed -$151K 1823
2026
Q1
$151K Sell
2,000
-55,206
-97% -$4.15M ﹤0.01% 1558
2025
Q4
$4.26M Sell
57,206
-3,707
-6% -$271K 0.02% 537
2025
Q3
$4.11M Sell
60,913
-187
-0.3% -$12.4K 0.02% 427
2025
Q2
$3.98M Buy
61,100
+5,100
+9% +$306K 0.03% 357
2025
Q1
$3.46M Sell
56,000
-40,849
-42% -$2.71M 0.03% 405
2024
Q4
$6.98M Buy
96,849
+56,742
+141% +$4.43M 0.04% 284
2024
Q3
$3.27M Buy
+40,107
New +$3.21M 0.02% 433
2024
Q1
Sell
-26,300
Closed -$1.88M 1787
2023
Q4
$1.88M Hold
26,300
0.01% 738
2023
Q3
$1.83M Sell
26,300
-5,200
-17% -$393K 0.02% 650
2023
Q2
$2.55M Buy
31,500
+24,699
+363% +$2.02M 0.02% 579
2023
Q1
$549K Sell
6,801
-32,299
-83% -$2.6M ﹤0.01% 1071
2022
Q4
$2.93M Buy
+39,100
New +$2.78M 0.02% 532

Other funds holding HOLX

Jefferies Financial Group's HOLX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,000 shares — an estimated $151K sold.

Jefferies Financial Group first reported a position in HOLX in Q4 2022 and held it in 12 quarters. The position peaked at $6.98M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 2,000 Hologic shares in Q2 2026, an estimated $151K.
  • Jefferies Financial Group first reported a position in Hologic in Q4 2022 and held it in 12 quarters.
  • Jefferies Financial Group's Hologic position peaked at $6.98M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.